Tag: Marketwatch

Sarepta Therapeutics Inc. SRPT, +5.14% shares plummeted as much as 20% in after-hours trading Thursday, after the company reported that a study had been put on hold by the Food and Drug Administration. Sarepta disclosed that a patient in a study of a proposed drug for Duchenne muscular dystrophy suffered a “serious adverse event of […]

Smith & Wesson Brands Inc. SWBI, +9.62% shares fell 3% in the extended session Thursday following a rally in the regular session and after the gun maker reported quarterly profit and revenue above Wall Street expectations. Smith & Wesson said it earned $36.1 million, or 79 cents a share, in the fiscal fourth quarter, compared […]

LendingTree Inc. TREE, +5.18% shares dove more than 13% in after-hours trading Thursday, after the lender trimmed its guidance for the quarter as a result of lower levels of home-mortgage loans. Executives said they now expect second-quarter revenue of $259 million to $264 million, after previously forecasting $283 million to $293 million, and also reduced […]

Gold futures ended lower on Thursday, with prices for the precious metal down a fourth straight session. Losses for gold are “mainly due to the strength in the dollar, as expectations are that [the Federal Reserve] may adopt even more hawkish monetary policy,” Naeem Aslam, chief market analyst at AvaTrade, told MarketWatch. In testimony before […]

The U.S. Food and Drug Administration said Thursday it has issued marketing denial orders to Juul Labs Inc. for all of its products that are currently marketed in the U.S., and ordered the company to remove all or risk enforcement action. The products in question comprise the Juul device and four types of pods; Virginia […]

Republicans in the North Carolina House of Representatives have decided not to take up a medical cannabis measure that had already been passed by the Senate, according to a report by Axios. The North Carolina Compassionate Care Act was approved by the state Senate in June. The measure would have allowed cannabis to treat cancer, […]

Rite Aid Corp. RAD, +6.17% shares rose 4.8% in Thursday premarket trading after the pharmacy retailer reported first-quarter revenue that beat expectations and raised its full-year guidance. Net loss totaled $110.2 million, or $2.03 per share, after a loss of $13.1 million, or 24 cents per share, last year. Adjusted loss per share of 60 […]

Steven Goldstein is based in London and responsible for MarketWatch’s coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was Washington bureau chief, directing MarketWatch’s economic, political and regulatory coverage. Follow Steve on Twitter: @MKTWgoldstein. Source: Marketwatch

Shares of Athira Pharma Inc. apha plummeted 66.9% toward a record low in active afternoon trading Wednesday, enough to make them the biggest decliners trading on major market indexes, after the biopharmaceutical company said a Phase 2 study of its Alzheimer’s treatment failed to meet the primary endpoint. Trading volume spiked up to 18.1 million […]

Gold futures ended slightly lower on Wednesday, with prices for the precious metal down a third straight session. Traders and investors are focused on inflation and energy prices, said Chintan Karnani, director of research at Insignia Consultants. However, a “near recession outlook for the second half of the year can cause a pause in interest-rate […]